Souhil Lebdai

<scp>TOOKAD</scp> ^® <scp>S</scp> oluble vascular‐targeted photodynamic ( <scp>VTP</scp> ) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer

Abdel‐Rahmène Azzouzi, Éric Barret, Caroline M. Moore et al. · British Journal of Urology · 2013 · 156 citations

Medicine, Oncology, Pharmacology +17

Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?

Pierre Bigot, T. Fardoun, Jean‐Christophe Bernhard et al. · World Journal of Urology · 2013 · 109 citations

Medicine, Molecular Medicine, Oncology +10

Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure

Abdel-Rahmène Azzouzi, Souhil Lebdai, Fawzi Benzaghou et al. · World Journal of Urology · 2015 · 90 citations · Full text

Medicine, Oncology, Pharmacology +16

Impact of oral anticoagulation on morbidity of transurethral resection of the prostate

A. Descazeaud, G. Robert, Souhil Lebdai et al. · World Journal of Urology · 2010 · 75 citations

Medicine, Surgery, Urology +14

Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials)

A. Noweski, Alexander Roosen, Souhil Lebdai et al. · European Urology Focus · 2018 · 67 citations · Full text

Medicine, Oncology, Biophotonics +15